Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hardwick

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Cell Biology|September 1, 1986
Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transportJ M Hardwick, K E Shaw, J W Wills, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoproteinS Ubol, P C Tucker, D E Griffin, et al.
Biotechnology and Bioengineering|January 29, 2000
Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectorsA J Mastrangelo, J M Hardwick, F Bex, et al.
Biotechnology and Bioengineering|September 15, 1999
Antiapoptosis chemicals prolong productive lifetimes of mammalian cells upon Sindbis virus vector infectionA J Mastrangelo, S Zou, J M Hardwick, et al.
Biotechnology and Bioengineering|January 29, 2000
Part II. Overexpression of bcl-2 family members enhances survival of mammalian cells in response to various culture insultsA J Mastrangelo, J M Hardwick, S Zou, et al.
Journal of Virology|June 1, 1995
Apoptosis as a cause of death in measles virus-infected cellsL M Esolen, S W Park, J M Hardwick, et al.
The Journal of Experimental Medicine|August 4, 1999
Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcriptionR K Srivastava, C Y Sasaki, J M Hardwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosisR K Srivastava, Q S Mi, J M Hardwick, et al.
Journal of Virology|September 1, 1992
The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16J M Hardwick, L Tse, N Applegren, et al.
Molecular Cell|August 19, 2000
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1B N Chau, E H Cheng, D A Kerr, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Cell Biology|September 1, 1986
Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transportJ M Hardwick, K E Shaw, J W Wills, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994
Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoproteinS Ubol, P C Tucker, D E Griffin, et al.
Biotechnology and Bioengineering|January 29, 2000
Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectorsA J Mastrangelo, J M Hardwick, F Bex, et al.
Biotechnology and Bioengineering|September 15, 1999
Antiapoptosis chemicals prolong productive lifetimes of mammalian cells upon Sindbis virus vector infectionA J Mastrangelo, S Zou, J M Hardwick, et al.
Biotechnology and Bioengineering|January 29, 2000
Part II. Overexpression of bcl-2 family members enhances survival of mammalian cells in response to various culture insultsA J Mastrangelo, J M Hardwick, S Zou, et al.
Journal of Virology|June 1, 1995
Apoptosis as a cause of death in measles virus-infected cellsL M Esolen, S W Park, J M Hardwick, et al.
The Journal of Experimental Medicine|August 4, 1999
Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcriptionR K Srivastava, C Y Sasaki, J M Hardwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosisR K Srivastava, Q S Mi, J M Hardwick, et al.
Journal of Virology|September 1, 1992
The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16J M Hardwick, L Tse, N Applegren, et al.
Molecular Cell|August 19, 2000
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1B N Chau, E H Cheng, D A Kerr, et al.
Pageof 7